Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics
- PMID: 10536365
- DOI: 10.1002/(sici)1097-4644(19991201)75:3<414::aid-jcb7>3.3.co;2-3
Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics
Abstract
Bone marrow contains a population of mesenchymal stem cells with the ability to differentiate into cells that form bone, cartilage, adipose, and other connective tissues. Stem cells can be isolated from bone marrow aspirates and expanded in vitro. Presently, most stem cells studies have been performed in cells obtained from "healthy" control subjects. The goal of this study was to compare the functional characteristics of mesenchymal stem cells derived from "healthy" control and osteoporotic postmenopausal women to better understand the mechanisms involved in the pathogenesis of this disease. Osteoporotic and control stem cells have similar morphology and size and express similar cell surface antigens as evidenced by their reactivity with cell specific monoclonal antibodies. Mesenchymal stem cells from osteoporotic women differ from controls in having a lower growth rate than control cells, being refractory to the mitogenic effect of IGF-1, and exhibiting a deficient ability to differentiate into the osteogenic linage as evidenced by the alkaline phosphatase activity and calcium phosphate deposition. We conclude that in osteoporosis stem cell growth, proliferative response and osteogenic differentiation are significantly affected. Also, the study of mesenchymal stem cells from osteoporotic postmenopausal women may provide a better understanding of the mechanisms involved in the pathogenesis of the osteoporosis. It may also serve to test in vitro in rapid manner novel new therapeutic strategies.
Copyright 1999 Wiley-Liss, Inc.
Similar articles
-
Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation.J Cell Biochem. 2000 Sep 14;79(4):557-65. doi: 10.1002/1097-4644(20001215)79:4<557::aid-jcb40>3.0.co;2-h. J Cell Biochem. 2000. PMID: 10996846
-
Effect of low-level laser therapy and oxytocin on osteoporotic bone marrow-derived mesenchymal stem cells.J Cell Biochem. 2018 Jan;119(1):983-997. doi: 10.1002/jcb.26265. Epub 2017 Sep 8. J Cell Biochem. 2018. PMID: 28681933
-
Autophagy promotes osteogenic differentiation of human bone marrow mesenchymal stem cell derived from osteoporotic vertebrae.Biochem Biophys Res Commun. 2017 Jun 17;488(1):46-52. doi: 10.1016/j.bbrc.2017.05.004. Epub 2017 May 3. Biochem Biophys Res Commun. 2017. PMID: 28476617
-
Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells.Alcohol Clin Exp Res. 2004 Mar;28(3):468-79. doi: 10.1097/01.alc.0000118315.58404.c1. Alcohol Clin Exp Res. 2004. PMID: 15084905
-
Presenting a Method to Improve Bone Quality Through Stimulation of Osteoporotic Mesenchymal Stem Cells by Low-Level Laser Therapy.Photomed Laser Surg. 2017 Nov;35(11):622-628. doi: 10.1089/pho.2016.4245. Epub 2017 Jun 15. Photomed Laser Surg. 2017. PMID: 28621568 Review.
Cited by
-
Naringin Stimulates Osteogenic Differentiation of Rat Bone Marrow Stromal Cells via Activation of the Notch Signaling Pathway.Stem Cells Int. 2016;2016:7130653. doi: 10.1155/2016/7130653. Epub 2016 Mar 16. Stem Cells Int. 2016. PMID: 27069482 Free PMC article.
-
The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.PLoS One. 2012;7(9):e45142. doi: 10.1371/journal.pone.0045142. Epub 2012 Sep 24. PLoS One. 2012. PMID: 23028809 Free PMC article.
-
Improvement in viability and mineralization of osteoporotic bone marrow mesenchymal stem cell through combined application of photobiomodulation therapy and oxytocin.Lasers Med Sci. 2020 Apr;35(3):557-566. doi: 10.1007/s10103-019-02848-8. Epub 2019 Aug 9. Lasers Med Sci. 2020. PMID: 31399862
-
Intracellular release of 17-β estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cells.Tissue Eng Part C Methods. 2011 Mar;17(3):319-25. doi: 10.1089/ten.TEC.2010.0388. Epub 2010 Nov 22. Tissue Eng Part C Methods. 2011. PMID: 20883116 Free PMC article.
-
The potential of gene therapy for fracture healing in osteoporosis.Osteoporos Int. 2005 Mar;16 Suppl 2:S120-8. doi: 10.1007/s00198-004-1817-9. Epub 2005 Jan 15. Osteoporos Int. 2005. PMID: 15654580 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous